Drug Database
Back to search

Sweden· SE-20210330000067

Nevirapin 2care4 400 mg Depottablett

A nevirapine product, registered in Sweden by 2care4 ApS. The same ATC class is registered in 16 of our 19 countries.

ATC J05AG01

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedNevirapin 2care4 400 mg DepottablettATCJ05AG01REGISTER NO.SE-20210330000067PACKS LISTED1CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about NevirapinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nevirapine is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AG01 (nevirapine), each read from that country’s own register.

  • This record: Sweden, from Swedish Medical Products Agency (Sweden)
  • 9 of them publish a price we can compare per daily dose
Search nevirapine products by name

Nevirapine · ATC J05AG01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nevirapine costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $3.81 in France to $7.77 in Switzerland — a ×2.0 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Nevirapine · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$7.77
  • FR France$3.81
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swedish Medical Products Agency (Sweden)
Manufacturer
2care4 ApS
Country
Sweden (SE)
ATC code
J05AG01
ATC class
Nevirapine
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20210330000067

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

316 interactions on record for nevirapine.

Graded by severity as the source publishes them — 26 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nevirapine against other medicinesHow interaction checks work

Nevirapine · interactions on record

316 records

  • 26 severe
  • 220 moderate
  • 8 minor
  • 49 info

Most severe, free to view

  • DeflazacortH02AB13severe
  • BrigatinibL01ED04severe
  • LorlatinibL01ED05severe
  • CobimetinibL01EE02severe

13 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J05AG01

Nevirapine, as other registers publish it.

All nevirapine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5d367e4-4efb-4c98-9833-36f75c8f859b
GET /v1/drugs/f5d367e4-4efb-4c98-9833-36f75c8f859b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL"
  ],
  "se_npl_id": "20210330000067",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20210330000067",
  "product_doc_link": "https://docetp.mpa.se/LMF/Nevirapin%202care4%20400%20mg%20prolonged-release%20tablet%20NL%20PL_09001bee81e9c92e.pdf"
}
API referenceMCP serverPlans

See everything about nevirapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console